Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New caspase activators and their use in cancer and autoimmune diseases

Jan. 2, 2003

Gleevec granted FDA approval for first-line treatment of CML

Jan. 2, 2003

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

Onconase receives fast track designation for malignant mesothelioma

Jan. 2, 2003

PSMA Development prostate cancer vaccine enters phase I

Jan. 2, 2003

GlycoGenesys acquires Elan's interest in joint venture

Jan. 2, 2003

Novel paclitaxel formulation ABI-007 evaluated in cancer patients

Jan. 2, 2003

Antitumor activity reported for CCI-779 in advanced/metastatic breast cancer

Jan. 2, 2003

Antitumor efficacy of virotherapy plus chemotherapy in gastrointestinal tumors

Jan. 2, 2003

Restrictions on the use of new lung cancer drug

Dec. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.